HIIT and Chronic Pain

What Is HIIT

HIIT (High-Intensity Interval Training) is an exercise modality in which short blocks of intense effort are alternated with periods of recovery, active or passive. Intensity during the work blocks typically lies between 80 and 95% of VO2 max (or between 85 and 95% of maximum heart rate), levels that could not be sustained for minutes on end in continuous format. The differential of HIIT is precisely this: to offer a high-grade cardiovascular and metabolic stimulus in short sessions, with total duration frequently between 15 and 30 minutes.

The difference relative to traditional continuous aerobic exercise is central to understanding the role of HIIT in chronic pain. Continuous aerobic exercise operates at sustained moderate intensity for 30 to 60 minutes; HIIT concentrates the stimulus in alternating peaks, with shorter total session time. In general populations, this time efficiency without loss of cardiovascular benefit is one of the main reasons for the popularization of the modality in the last decade. In chronic pain, the same attribute is relevant for an additional reason — patients with tight schedules and energy limitations tolerate short sessions better than long blocks of exercise.

Three classic protocols form the basis of practice. Tabata, described by Izumi Tabata in 1996, consists of 8 cycles of 20 seconds of maximum effort alternated with 10 seconds of rest — 4 minutes of work, preceded and followed by warm-up and cool-down. The Norwegian 4x4 protocol, developed by Scandinavian groups in cardiovascular research, uses 4 blocks of 4 minutes at 85-95% of max HR interspersed with 3 minutes of active recovery — total session of about 40 minutes. HIIE (High-Intensity Interval Exercise), in variants such as the one studied by Zumbrunnen, employs 10 cycles of 1 minute of intense effort alternated with 1 minute of recovery, in approximately 25 effective minutes.

In chronic pain, adaptation of these structures is essential. Instead of demanding 80-95% of absolute VO2 max — a parameter applicable to athletes or healthy populations —, training is performed at intensity relative to the patient: RPE (Rating of Perceived Exertion) 7-8 on the 0-10 scale, or Borg 15-17 on the traditional scale. What is "high" for a deconditioned fibromyalgia patient does not correspond to what is "high" for an amateur runner, and this individual calibration is what separates clinically safe HIIT from HIIT inappropriate for the population.

Mechanism of Action

The mechanisms by which HIIT acts on chronic pain are essentially the same as continuous aerobic exercise — with one important difference: the high-intensity stimulus tends to amplify part of these pathways. The central axis remains the sustained increase in BDNF, stimulation of hippocampal neurogenesis, release of endorphins and serotonin, and regulation of the hypothalamic-pituitary-adrenal axis. What changes with HIIT is the magnitude and speed with which some of these adaptations appear to occur, in addition to a particular profile of exercise-induced hypoalgesia.

The increase in BDNF associated with HIIT, documented in experimental studies by Gibala and colleagues (J Physiol, 2012), appears to respond with particular robustness to intensity peaks. The vigorous stimulus activates signaling pathways — AMPK, PGC-1alpha, transcription factors related to mitochondrial biogenesis — that promote central and peripheral adaptations in less time than moderate aerobic exercise. Clinically, this translates into measurable cardiovascular conditioning gains in 4-6 weeks of HIIT, a frequently longer time frame in continuous aerobic protocols of equivalent time volume.

Exercise-induced hypoalgesia (EIH) — transient reduction of pain sensitivity after a session of activity — also has a specific profile in HIIT. The literature suggests that vigorous intensities produce a magnitude of EIH potentially greater than moderate intensities, at least in the acute post-session phase. The basis of this effect involves activation of the endogenous opioid system, descending inhibitory modulation (periaqueductal gray, nucleus raphe magnus), and endocannabinoid circuits, all sensitive to the intensity of the stimulus.

The systemic anti-inflammatory effect of HIIT is comparable, and in some parameters superior, to that of moderate aerobic exercise. Studies show reduction of baseline IL-6, elevation of IL-10, and attenuation of low-grade inflammation markers in 8-12 week programs. In patients with chronic pain and subclinical inflammation associated with sedentary lifestyle, this is one of the mechanisms by which cardiovascular reconditioning — by HIIT or by continuous aerobic — produces global benefit.

The central clinical differential of HIIT, however, is not mechanistic but pragmatic: time efficiency improves adherence in patients with tight routines or low tolerance to prolonged sessions. A patient who cannot allocate 60 minutes three times a week for walking may be able to manage 25 minutes three times a week in a supervised HIIT protocol. This difference is clinically real: the best protocol is the one the patient can sustain, and, for a subgroup, HIIT fills this gap where continuous aerobic cannot.

Scientific Evidence

The evidence for HIIT in chronic pain is consistently positioned as emerging — under construction, with promising results, but not yet at the confidence level of continuous aerobic exercise. Most trials have been published in the last 10 years, with small samples, heterogeneous protocols, and short follow-up. It is a field in active expansion, in which estimates of effect available today will likely be refined as larger multicenter trials are published.

The central reference in fibromyalgia is the study by Atan et al. (Rheumatol Int, 2020), which compared HIIT to moderate-intensity continuous aerobic exercise in patients with fibromyalgia. The main finding was comparable benefit between the two modalities in pain, function, and quality-of-life outcomes, with the advantage of HIIT in time efficiency — significantly shorter sessions produced equivalent clinical effect. The study had a modest sample size and 12-week follow-up, which limits extrapolation to long-term sustained effect.

The Cochrane update by Bidonde and colleagues on exercise in fibromyalgia — a review that consolidated decades of aerobic and resistance trials — positions exercise globally as first line with strong recommendation. Although HIIT itself appears in specific subsets of the reviewed literature, the EULAR 2017 guideline and the Cochrane review anchor moderate continuous aerobic exercise as the established reference; HIIT emerges as an alternative with growing evidence, but not yet substitutive.

The physiological basis for HIIT's time advantage is well documented in work outside the specific domain of chronic pain. Gibala and colleagues (J Physiol, 2012) consolidated evidence that HIIT produces mitochondrial, cardiovascular, and metabolic adaptations comparable or superior to much larger volumes of traditional aerobic exercise. This work, classic in exercise physiology literature, provides the mechanistic basis that justifies the interest in transposing the modality to clinical populations, including chronic pain.

The systematic review by Jimenez-Garcia et al. (Int J Environ Res Public Health, 2020) on HIIT in chronic pain aggregated trials in fibromyalgia, chronic low back pain, and musculoskeletal pain in general. The conclusion was favorable — significant benefit in multiple outcomes, with adequate safety profile when properly protocolled —, but the review was also explicit about the methodologic limitations of the body of literature: small samples, heterogeneous protocols (intensity, duration of intervals, weekly frequency), absence of multicenter studies, and typical follow-up of 8-16 weeks.

In chronic low back pain, small trials have explored HIIT as an alternative to continuous aerobic exercise, with promising results in pain and function outcomes — but the body of evidence is still substantially smaller than that of moderate aerobic or combined exercise. For other chronic pain conditions (osteoarthritis, neuropathic pain), data are preliminary or nonexistent. The honest synthesis of the current literature is: HIIT is promising, but not established as a universal first line; its current indication is in selected patients, with qualified supervision.

Adapted Protocols

The original HIIT protocols were designed for healthy populations — athletes, university students, adults without relevant comorbidities. In chronic pain, adaptation of these structures is necessary in two main dimensions: relative (not absolute) intensity and slower progression than usual. The table below summarizes reference protocols and their typical adjustments for chronic pain patients.

Adaptation principles in chronic pain

Progression in chronic pain is systematically slower than in athletic populations. While an amateur runner can progress from 5 to 8 cycles of Tabata in two weeks, a fibromyalgia patient may need 6-8 weeks for the same progression — and this slower pace is not failure, it is appropriate calibration to the clinical substrate. Trying to compress the adaptation time is one of the most frequent errors that lead to pain exacerbation and program abandonment.

Intensity is gauged on a relative scale — RPE 7-8 on the 0-10 scale ("heavy" to "very heavy"), or Borg 15-17 ("quite heavy") — rather than absolute percentage of VO2max. What characterizes a HIIT block is the inability to converse in complete sentences during the effort, associated with a clear elevation of respiratory and heart rate, always within what the patient reports as tolerable. This respects individual baseline conditioning without imposing a metric that would require ergospirometric testing.

The ideal weekly frequency in chronic pain is 2 to 3 sessions per week — no more. Additional sessions do not produce measurable extra benefit in chronic pain patients, and the risk of fatigue accumulation and exacerbation is real. The principle "more is better," valid in low to moderate doses of exercise, does not apply to HIIT in clinical populations: recovery between sessions is as important a part of the protocol as the session itself.

Qualified supervision is essential, especially in the initial phase. The risk of pain exacerbation, of cardiovascular exacerbation in unstratified patients, and of technical execution error is sufficiently greater than in moderate aerobic exercise to make supervision (by a sports physician, physiatrist, physician acupuncturist with training in clinical exercise, or physical educator trained in special populations) a practical component of the program, not an optional add-on.

Indications

Indications for HIIT in chronic pain reflect the evidence profile — good in specific scenarios, restricted by safety and baseline conditioning prerequisites. Appropriate patient selection is the most important variable for therapeutic success: HIIT applied outside the appropriate window is one of those situations where exercise stops being a favorable intervention and becomes unnecessary risk.

How It Is Done

The clinical plan for HIIT in chronic pain is structured in phases, with prior cardiovascular evaluation, gradual introduction, and careful transition from continuous aerobic exercise when that is the starting point. The choice of modality within HIIT — stationary bike, elliptical, inclined treadmill walking, moderate running — follows the principle of lower joint impact in patients with musculoskeletal pain and patient preference as tiebreaker.

The prior cardiovascular evaluation is more rigorous than required for moderate aerobic exercise. History focused on risk factors (hypertension, diabetes, dyslipidemia, smoking, family history), complete physical examination with measurement of blood pressure at rest and after light effort, resting ECG, and, in patients > 50 years or with multiple risk factors, exercise stress test or ergospirometry for stratification. Formal medical clearance — documented — is a routine part of the prescription, not bureaucratic formality.

A crucial clinical point: HIIT in a completely deconditioned patient is not appropriate as an entry point. In patients sedentary for years, the protocol preceded by at least 4-6 weeks of moderate continuous aerobic exercise is a practical rule. Trying to start HIIT directly in a patient without any cardiovascular base is the most frequent error I see, both in online guidance and in hasty referrals — and what most leads to pain exacerbation and abandonment in the first month.

Risks and Contraindications

The risk profile of HIIT is more demanding than that of moderate aerobic exercise, precisely because of the level of intensity involved. Absolute contraindications are severe cardiologic and metabolic; relative ones include conditions that require case-by-case evaluation and, frequently, modified protocol rather than total exclusion. Prior cardiovascular stratification is the central element of safety — it is not optional in at-risk populations.

Expected effects and warning signs

Three situations are part of the expected course in the first weeks and should not be confused with failure or risk: intense post-session fatigue in the first 24 hours, particularly in the initial phase; delayed-onset muscle soreness (DOMS) in the first 3-4 sessions of new protocols, reflecting physiologic muscle adaptation; and dyspnea during intense block, which is expected and part of the definition of the stimulus — if the patient can converse during the block, intensity is not at the appropriate level.

What distinguishes an expected effect from a warning sign is the pattern. Chest pain, syncope, presyncope, sustained palpitations during or after the session, fatigue lasting more than 48-72 hours and impeding normal activity, or exacerbation of chronic pain that persists for more than two weeks without stabilization — any of these signs requires interruption of HIIT and medical reassessment before resumption.

The rare but real risk that justifies all the emphasis on prior screening is the acute cardiovascular event in an unstratified patient — infarction, malignant arrhythmia, sudden death in vigorous exercise in an individual with unknown CAD. The incidence is low, but not zero, and is the central reason why HIIT without prior cardiovascular evaluation in patients > 50 years or with risk factors is a practice to be avoided even when the patient "feels fine."

Limitations and What Is Not Yet Known

Despite growing interest and promising results in specific subgroups, the literature on HIIT in chronic pain carries substantial limitations that shape realistic clinical use — both to avoid premature enthusiasm and to preserve the modality's real place in appropriately selected patients.

Gaps and practical challenges

Small and heterogeneous RCTs. Most HIIT trials in chronic pain have sample sizes of fewer than 100 patients, with protocols that vary substantially — different block durations (20s, 1 min, 4 min), different work-to-recovery ratios, different weekly frequencies, different modalities (bike, treadmill, elliptical). This heterogeneity makes robust meta-analyses and precise dose-response estimates difficult, limiting the strength of aggregated conclusions compared with continuous aerobic exercise, whose literature is far more uniform.

Typically short follow-up. Most studies evaluate outcomes at 8-16 weeks; data on maintenance at 6-12 months are scarce. This is particularly relevant in chronic pain, a condition requiring long-term management — an intervention that appears to work at 12 weeks but whose adherence or efficacy decays substantially by 6 months has less clinical value than one with benefits sustained over years. For HIIT, this sustainability profile is not yet well characterized.

Less established safety profile in comorbidities. Moderate aerobic exercise has decades of safety data in populations with diabetes, stable cardiac disease, and frail older adults. As a more recent modality in clinical practice involving greater intensity, HIIT has a smaller accumulated safety base in these subgroups. What is known is sufficient for careful prescription in appropriately stratified patients, but the exact boundary between "safe with supervision" and "unnecessary risk" in each comorbidity is still an active research frontier.

Non-responders little studied. For continuous aerobic exercise, about 20% of fibromyalgia patients are known not to respond clinically to a well-adhered program. For HIIT, this characterization is even more preliminary — the best-responding subgroups, the non-responders, and robust clinical predictors of response are not well described. This limits the ability to recommend or rule out HIIT precisely for a specific patient before starting the program; evaluation at 8-12 weeks of a well-executed protocol remains the main way to establish individual response.

Relationship to Medical Acupuncture

HIIT and medical acupuncture operate in largely distinct domains of chronic pain, with a small area of overlap and a complementary practical role when both are indicated. HIIT acts mainly on cardiovascular conditioning, central adaptation to high-intensity stimulus, and sustained pain modulation in nociplastic conditions with deconditioning component. Medical acupuncture acts predominantly on central pain processing, segmental modulation, deactivation of myofascial trigger points — fields in which HIIT has little or no direct effect.

The practical synergy between the two modalities is clinically interesting. Medical acupuncture, in responding patients, can reduce baseline pain in magnitude sufficient to allow initial tolerance to HIIT — especially in the first weeks, when the combination of baseline pain with adaptive exacerbation frequently leads to abandonment. One or two weekly sessions of acupuncture during phase 1 of the HIIT protocol is a reasonable strategy in patients with a significant myofascial component or central sensitization.

Over a longer horizon, the division of roles favors HIIT as sustenance of cardiovascular conditioning and continuous central adaptation, with acupuncture as punctual modulation in exacerbations or transition periods. There is no documented negative interaction between the modalities — they can be used in sequence, on different days, or in parallel schedules according to patient routine. The combination, when indicated, tends to add effects, not to subtract them or render them redundant.

When to Seek Medical Care

The decision to start HIIT in chronic pain should obligatorily pass through medical evaluation — at a more rigorous level than required for moderate aerobic exercise. The intensity of the stimulus and the associated risk profile make prior cardiovascular stratification a safety condition, not a procedural formality. In patients with risk factors, "starting and seeing what happens" is one of the approaches that most produces avoidable adverse events.